| |
| |
|
| Insider
Information: |
Ajer Jeffrey Robert |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
100,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,973,570 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
100,920 |
|
|
| Total
Value |
$5,973,570 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -21.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-06-19 |
4 |
OE |
$63.10 |
$946,500 |
D/D |
15,000 |
78,402 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-06-19 |
4 |
AS |
$124.00 |
$1,860,000 |
D/D |
(15,000) |
63,402 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-21 |
4 |
AS |
$19.74 |
$44,415 |
D/D |
(2,250) |
20,125 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,100 |
29,225 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-28 |
4 |
AS |
$17.25 |
$56,063 |
D/D |
(3,250) |
25,975 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-10-14 |
4 |
AS |
$79.91 |
$169,489 |
D/D |
(2,121) |
61,281 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,720 |
72,001 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-15 |
4 |
D |
$78.39 |
$413,350 |
D/D |
(5,273) |
66,728 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-16 |
4 |
D |
$77.21 |
$99,369 |
D/D |
(1,287) |
65,441 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-18 |
4 |
AS |
$77.99 |
$102,011 |
D/D |
(1,308) |
64,133 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-22 |
4 |
D |
$78.52 |
$118,801 |
D/D |
(1,513) |
62,620 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-24 |
4 |
AS |
$76.30 |
$90,110 |
D/D |
(1,181) |
61,439 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-30 |
4 |
AS |
$74.79 |
$123,553 |
D/D |
(1,652) |
59,787 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-04-08 |
4 |
AS |
$78.81 |
$121,131 |
D/D |
(1,537) |
58,250 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-04-30 |
4 |
A |
$62.41 |
$21,343 |
D/D |
342 |
58,592 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2021-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
36,175 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2021-09-22 |
4 |
S |
$17.78 |
$65,164 |
D/D |
(3,665) |
32,510 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-10-26 |
4 |
AS |
$73.60 |
$201,590 |
D/D |
(2,739) |
55,853 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,370 |
65,223 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,940 |
77,163 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-15 |
4 |
D |
$78.27 |
$658,877 |
D/D |
(8,418) |
68,745 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-16 |
4 |
D |
$80.72 |
$103,887 |
D/D |
(1,287) |
67,458 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-22 |
4 |
AS |
$81.00 |
$167,913 |
D/D |
(2,073) |
65,385 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-23 |
4 |
AS |
$81.78 |
$501,230 |
D/D |
(6,129) |
59,256 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-29 |
4 |
AS |
$79.43 |
$128,518 |
D/D |
(1,618) |
57,638 |
0 |
- |
|
174 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
